DANAHER CORPORATION (NYSE:DHR) Files An 8-K Results of Operations and Financial Condition

On July20, 2017, Danaher Corporation (“Danaher”) issued a press release announcing financial results for the quarter ended June30, 2017. A copy of the release is furnished herewith as Exhibit 99.1 and incorporated by reference herein. This Current Report on Form 8-K and the press release attached hereto are being furnished by Danaher to Item 2.02 of Form 8-K.

This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

DANAHER CORP /DE/ ExhibitEX-99.1 2 dhr-2017720xex991.htm EX 99.1 Exhibit Exhibit 99.1DANAHER REPORTS SECOND QUARTER 2017 RESULTSWASHINGTON,…To view the full exhibit click here
About DANAHER CORPORATION (NYSE:DHR)
Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services. Its Environmental segment products and services help protect the water supply, enhance the safety of personal data and improve business efficiencies. In the Life Sciences & Diagnostics segment, its diagnostics business offers analytical instruments, reagents, consumables, software and services. Its life sciences business offers research tools. Its Dental segment provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. Its Industrial Technologies segment solutions help protect the world’s food supply, improve packaging design and quality, and verify pharmaceutical dosages.